Detalhe da pesquisa
1.
"The least significant change on bone mineral density scan increased in patients with higher degrees of obesity".
Aging Clin Exp Res
; 36(1): 98, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38652346
2.
Cluster analysis unveils a severe persistent respiratory impairment phenotype 3-months after severe COVID-19.
Respir Res
; 23(1): 199, 2022 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35918719
3.
Association between obesity-related dyspnea in daily living, lung function and body composition analyzed by DXA: a prospective study of 130 patients.
BMC Pulm Med
; 22(1): 103, 2022 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35337302
4.
Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparison.
Rheumatology (Oxford)
; 60(6): 2773-2782, 2021 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33232465
5.
Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data.
Rheumatology (Oxford)
; 57(1): 134-139, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29069471
6.
[Effectiveness, therapeutic maintenance and reasons for stopping tocilizumab (TCZ): A retrospective and monocentric study in 88 patients followed for rheumatoid arthritis (RA) at the Reims university hospital]. / Efficacité, maintien thérapeutique et motifs d'arrêt du tocilizumab (TCZ) : étude monocentrique et rétrospective chez 88 patients suivis pour une polyarthrite rhumatoïde (PR) au CHU de Reims.
Therapie
; 73(3): 231-236, 2018.
Artigo
em Francês
| MEDLINE | ID: mdl-29146040
7.
B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics.
Ann Rheum Dis
; 81(1): 143-145, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34556483
8.
Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical Trial.
JAMA
; 316(11): 1172-1180, 2016 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27654603
9.
[Efficacy and safety of ustekinumab in psoriatic arthritis after anti-TNFα failure in routine practice]. / Ustekinumab dans le rhumatisme psoriasique après échec des anti-TNFα en pratique courante.
Therapie
; 71(3): 281-6, 2016 Jun.
Artigo
em Francês
| MEDLINE | ID: mdl-27235651
10.
Urinary methotrexate dosage in rheumatoid arthritis, in patients treated for at least 6 months: a potential marker of adherence.
RMD Open
; 10(2)2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38772677
11.
Retention rate of subcutaneous TNF inhibitors in axial spondyloarthritis in a multicentre study from the RIC-FRANCE network.
Sci Rep
; 14(1): 1374, 2024 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38228719
12.
Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission.
Arthritis Rheumatol
; 76(4): 541-552, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37942714
13.
Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey.
Hum Vaccin Immunother
; 20(1): 2334084, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38563792
14.
Prognostic Factors Related to Clinical Response in 210 Knees Treated by Platelet-Rich Plasma for Osteoarthritis.
Diagnostics (Basel)
; 13(4)2023 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36832248
15.
Clinical relevance of low bone density in cystic fibrosis adult patients: A pilot study.
Medicine (Baltimore)
; 102(1): e32227, 2023 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36607849
16.
Recommendations for assessing the risk of cardiovascular disease and venous thromboembolism before the initiation of targeted therapies for chronic inflammatory rheumatic diseases.
Joint Bone Spine
; 90(5): 105592, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37201575
17.
A new pharmacokinetic model of urinary methotrexate to assess adherence in rheumatoid arthritis.
Biomed Pharmacother
; 168: 115620, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37864897
18.
The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis.
Rheumatol Ther
; 10(1): 73-93, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36227530
19.
Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients.
Rheumatol Ther
; 10(6): 1575-1595, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37755648
20.
Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study.
Dig Liver Dis
; 55(1): 61-68, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35985961